Search Results

explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." GPCRs in the Background, But Always Present Even though his primary focus wasn’t GPCRs themselves, Serafini Takeaway Forget what you think you know about GPCR drug targets. data platform , GPCR training program , pain research , opioid signaling .

Discovery programs rarely fail because of one experiment. across purinergic programs. binding, and integrated discovery support — systems trusted across pharma, biotech, and regulatory programs and organizations positioned to use them — strengthening the bridge between platform expertise and program It strengthens teams executing discovery programs.

mutated GPCRs. Terry's Corner – How Enzyme Inhibition Shapes Every Discovery Program Every molecule meets an enzyme Your Membership Gives You: Proven frameworks used in real discovery programs On-demand lessons built insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost = a full year of expert training If your program depends on seeing around corners—enzyme liabilities, signaling bias, translational risks—Premium

GPCR. GPCR Dr. GPCR is a nonprofit organization connecting the global GPCR community through training, curated scientific Through educational programs, media initiatives, and a growing partner ecosystem, Dr. GPCR supports scientists and organizations advancing GPCR biology and GPCR-targeted drug discovery.

GPCR – Precision Tools for GPCR Assays Dr. GPCR and Celtarys Research have teamed up. features a discussion about a scalable GPCR-RAMP assay. Their global resource is now helping labs decode GPCR biology at scale. It’s exciting to see how the GPCR field is evolving. GPCR Team

GPCR . GPCR’s educational programs and global GPCR community, visit https://www.ecosystem.drgpcr.com About Dr GPCR Dr. GPCR is a nonprofit organization connecting the global GPCR community through training, curated news With over 180 podcast episodes , live and on-demand educational programs, and a growing partner ecosystem

Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug The interpretation of high and low affinity binding sites on GPCRs. GPCR Premium Membership Gives You an Edge Dr. GPCR Premium gives you an edge in a fast-moving field.

That's why we created GPCR Happy Hour. On April 29th, the Dr. Who's making the GPCR Happy Hour evening possible GPCR Happy Hour is made possible by four companies programs depend on. The first company to offer access to recombinant GPCR assays. programs need at the lead selection stage.

His work highlights how foundational GPCR science can drive therapeutic innovation. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery. Ready to dive deeper into GPCR drug discovery? Want to push the boundaries of GPCR drug discovery? Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community , GPCR drug discovery, mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR

But your GPCR program still isn't moving at the pace it should. So, I created a new path—one that allows me to embed, optimize, and accelerate GPCR programs from the The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes Ready to Move Your GPCR Program Forward? If you're navigating a stuck GPCR program, planning your next crucial milestone, or struggling to gain

operational strategy and investment goals, even the most promising program can falter. This fundamental disconnect between the lab and the boardroom  is precisely where programs get stuck—not This is the essence of de-risking GPCR programs through operational excellence. the entire GPCR program as a single, interconnected entity. If you're ready to move beyond the articles and build these systems for your own GPCR program, let's

GPCR Allosteric Modulators as Intracellular Molecular Glues Standard models attribute signaling specificity Examples spanning GPCR families A, B, and T suggest that interface-directed modulation may represent From the Masterclass Library This week's featured course from the Masterclass Library: GPCR Projects: GPCR Course Attendee About Dr. GPCR Dr. GPCR is the intelligence and community platform for GPCR scientists.

Target-based screening is now a fundamental pillar of drug development, and GPCRs are key targets for How Fluorescence Polarization Assays Work: Principles and Applications in GPCR Research FP assays work Optimizing GPCR Drug Discovery with Fluorescence Polarization: Key Advantages and Future Perspectives Compatible with various sources of GPCRs. Contact us  to drive further advancements in GPCR drug discovery!  

GPCR Allosteric Modulators as Novel Intracellular Molecular Glues Classic models explain biased signaling Reserve your spot ➤ iPSC-Derived Systems for GPCR Signaling and Translation Heterologous systems such Key implications: iPSC-derived cardiomyocytes reveal GPCR signaling behaviors that differ from HEK293 GPCR Dr. GPCR brings together scientists working across GPCR biology, pharmacology, and drug discovery to examine

Taken together, the lineup spans biophysics, kinetics, spatial biology, subcellular regulation, and program how kinetics shape drug action, and how all of it translates into programs. Andrew Tobin  — How to Build Breakthrough GPCR Programs. June 4. GPCR community gathers in person next week. GPCRs Targeted Drug Discovery Summit  — April 28–30. GPCR Dr. GPCR is the intelligence and community for GPCR scientists.

we explore how computational tools—especially AlphaFold —are helping crack the mystery of olfactory GPCRs The Problem: Hundreds of Receptors, Almost No Ligands Alessandro’s work focuses on olfactory GPCRs—nearly : Predicting the “Face” of a Receptor When Alessandro began his PhD, structural models of olfactory GPCRs —Alessandro Nicoli A New Era of GPCR Research AlphaFold didn’t just fill a gap—it shifted the focus of Start with our GPCR training program and get hands-on with virtual tools shaping the future of drug discovery

His group is trained to explain exactly what a model can predict and where its limits are. to stay plugged into the fast-changing needs of biotech while keeping his academic mission intact: training The GPCR Challenge What makes collaboration non-negotiable in GPCR research is the biology itself. The most effective discovery programs are structured like Carlsson’s: modeling designed with downstream GPCR Models Don’t Discover Drugs—People Do In GPCR research, the biggest breakthroughs won’t come from

GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet However, over half of non-sensory GPCRs do not have drugs available in the clinic, opening the door to This means fluorescent probes enable a dynamic observation of GPCRs. common starting point for employing fluorescent probes in GPCR assays. Fluorescent ligands: Bringing light to emerging GPCR paradigms.

Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. My Consulting Philosophy Every successful GPCR program is a blend of scientific excellence  and operational Program Moving Again Whether you’re building from scratch or recovering from a stall, I’ll help you program needs. 👉 https://calendly.com/drgpcr/yamina-corner Or explore how we can work together: 👉 Let’s talk through your program—no pitch, just clarity.

That’s exactly why we created GPCR Happy Hour . GPCR’s nonprofit mission to unite and empower the GPCR community worldwide FOMO is real: if you’re not Be Part of the GPCR Community Dr. GPCR is a nonprofit global community  dedicated to building a strong, connected GPCR ecosystem. GPCR Happy Hour is more than a social event.

GPCR signaling wasn’t linear. It wasn’t clean. For years, the GPCR community wrestled with unreliable antibodies. And some simply misled entire research programs. Why GPCR Collaboration Is Essential for Modern Science Hodson makes the point bluntly: modern GPCR science Together, they push GPCR science faster.

GPCR and Revvity. But there was a pivot: the tech had untapped potential for GPCRs. GPCR internalization isn’t just a trafficking readout—it’s pharmacology. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

space focused on GPCR pharmacology. – GPCR mutations in cancer—drivers, passengers, or both?  GPCR Updates Learn Pharmacology That Drives Discovery  – From Dr. GPCR Podcast appearance. GPCR Team

ability to access the right framework, detect risk early, and act on emerging signals determines whether programs Identify the exact knowledge gap slowing your program—and close it efficiently. many discovery programs fail because early safety signals were underestimated—or missed entirely. Equip your team with repeatable training resources in one place. It strengthens teams executing discovery programs.

Most GPCR programs don’t fail because of weak molecules—they fail because biology behaves differently teams from the costly misinterpretations that derail programs. you see the distortions baked into the system, you interpret your data differently and protect your program GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. Programs: Overcoming Assay Limitations with Fluorescent Ligands High-content screening (HCS) is now

High-content screening (HCS) has become a cornerstone in GPCR and phenotypic drug discovery, enabling For GPCR-focused programs, the ability to visualize receptor localization, internalization kinetics, Programs High-content screening integrates automated microscopy, multiplexed imaging, and computational The resulting multiparametric datasets are well-suited for GPCR research, where receptor trafficking, For GPCR assay developers, HCS supports:  Quantitative visualization of receptor internalization and

GPCR Ecosystem: sharper programming, deeper expertise, and renewed momentum across everything we publish We have shifted to continuous, coordinated programming  across Weekly News, Terry’s Corner, the Podcast Pharmacokinetics isn’t a late-stage checkbox—it’s a decision framework that shapes every viable drug discovery program With new courses, expanded programming, upcoming partnerships, and deeper community engagement ahead, GPCR Team

New structural tools, AI-driven design pipelines, and a growing number of programs moving into the clinic This year's program reflects where science is actually heading. Dr. GPCR founder Dr. from biotech and pharma to advance GPCR programmes from discovery through translation — experts in GPCR Alphamol on Phase 1 results from an orphan GPCR program pursued against industry skepticism. 🎥 Speaker program in every chapter of it.

s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors of GPCR-targeting As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every You’ll see how this manifests in real data from muscarinic receptors, CCR5 chemokine programs, and NMDA But without understanding how GPCR state changes  influence that affinity—or vice versa—drug discovery Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science.

traditional displacement logic breaks down in allosteric systems, and how overlooking this can derail entire programs Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. a masterful teacher and communicator." — DrGPCR University Attendee The difference between stalled programs